ALCEDIAG biomarkers for better health

Clinical Biomarkers

A set of biomarkers to optimize clinical studies and improve their outcomes in neuropsychiatry

ALCEDIAG, Medical and psychiatric diagnosis

Clinical Biomarkers

A set of biomarkers to optimize clinical studies and improve their outcomes in neuropsychiatry

EDIT–B

The first blood test to diagnose bipolar disorder and to differentiate patients with bipolar disorder from patients with depression

EDIT–B

The first blood test to diagnose bipolar disorder and to differentiate patients with bipolar disorder from patients with depression

EDITECH

A unique platform to discover and validate tailor-made biomarkers in CNS, oncology, inflammation and other therapeutic areas.

EDITECH

A unique platform to discover and validate tailor-made biomarkers in CNS, oncology, inflammation and other therapeutic areas.

The RNA editing company

ALCEDIAG has unique experience and expertise in RNA editing

More than ten years of R&D
Successful clinical trials
Several publications
Registered and granted patents worldwide

The RNA editing company

ALCEDIAG has unique experience and expertise in RNA editing

More than ten years of R&D
Successful clinical trials
Several publications
Registered and granted patents worldwide

ALCEDIAG solutions provide simple, objective and rapid assistance in the diagnosis of pathologies like depression or bipolar disorder. The use of such solutions is key to saving valuable time, allowing health professionals to accelerate personalized therapeutic decisions and improve patients’ quality of life.

Doctor Jean-Philippe Lang, Psychiatrist